This statistic depicts the cost of developing a new drug in the United States from the 1970s to the early 2010s. In the 1970s, the cost of developing a new pharmaceutical drug stood at approximately 179 million U.S. dollars.
- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Pharmaceuticals: cost of drug development in the U.S. since 1975
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Cost of developing a drug in the U.S. from the 1970s until today (in million U.S. dollars)*
Exclusive Premium Statistic
This statistic depicts the cost of developing a new drug in the United States from the 1970s to the early 2010s. In the 1970s, the cost of developing a new pharmaceutical drug stood at approximately 179 million U.S. dollars.
Exclusive content
Exclusive Premium statistic
Get a Premium Account for unrestrained access.
Benefits of our Premium membership:
- Access to all Premium statistics
- Download as XLS, PNG and PDF
- Detailed source and background information
Premium Account
$49 per month*
(billed annually)
(billed annually)
| Cost in million U.S. dollars | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| Cost in million U.S. dollars | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
Exclusive content
Exclusive Premium statistic
Get a Premium Account for unrestrained access.
Benefits of our Premium membership:
- Access to all Premium statistics
- Download as XLS, PNG and PDF
- Detailed source and background information
Premium Account
$49 per month*
(billed annually)
(billed annually)
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
This statistic depicts the cost of developing a new drug in the United States from the 1970s to the early 2010s. In the 1970s, the cost of developing a new pharmaceutical drug stood at approximately 179 million U.S. dollars.
Show more- Show sources information
- Show publisher information
- Release date
- May 2016
- Region
- United States
- Survey time period
- 1975 to 2016
- Supplementary notes
-
PhRMA stands for Pharmaceutical Research and Manufacturers of America.
* Including the cost of failures.
** Previous research by the same author estimated average R&D costs in the early 2000s at $1.2 billion in constant 2000 dollars (see DiMasi JA, Grabowski, HG. The cost of biopharmaceutical R&D: is biotech different? Manage Decis Econ. 2007;28:469-479). That estimate was based on the same underlying survey as the author’s estimates for the 1990s to early 2000s reported here ($800 million in constant 2000 dollars), but updated for changes in the cost of capital.
More information
- Region
- United States
- Survey time period
- 1975 to 2016
- Supplementary notes
-
PhRMA stands for Pharmaceutical Research and Manufacturers of America.
* Including the cost of failures.
** Previous research by the same author estimated average R&D costs in the early 2000s at $1.2 billion in constant 2000 dollars (see DiMasi JA, Grabowski, HG. The cost of biopharmaceutical R&D: is biotech different? Manage Decis Econ. 2007;28:469-479). That estimate was based on the same underlying survey as the author’s estimates for the 1990s to early 2000s reported here ($800 million in constant 2000 dollars), but updated for changes in the cost of capital.
Other interesting statistics
+
+Top pharmaceutical companies located in Canada by revenue 2016
+
+World pharmaceutical sales 2015-2017 by region
+
+Top 50 pharmaceutical companies - Rx sales and R&D spending 2017
+
+Pfizer's total revenue 2006-2017
+
+Johnson & Johnson's total revenue 2005-2017
+
+Leading countries in life sciences sector M&As 2017
Statista Accounts: Access All Statistics. Starting from $588 / Year
Statistics on "U.S. pharmaceutical industry"
- Contribution to global pharma
The most important statistics
- Distribution of the total global pharmaceutical market sales from 2014 to 2017, by submarket*World pharmaceutical market distribution by submarket 2014-2017
- Global pharmaceutical sales from 2015 to 2017, by region (in billion U.S. dollars)*World pharmaceutical sales 2015-2017 by region
- Market share of top 10 national pharmaceutical markets worldwide in 2016*Market share of the leading 10 global pharmaceutical markets 2016
- Growth of top 10 national pharmaceutical markets worldwide from 2011 to 2016*Top 10 global pharmaceutical markets: growth 2011-2016
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2017 (in billion U.S. dollars)Top 50 pharmaceutical companies - Rx sales and R&D spending 2017
- Leading countries in global life sciences mergers and acquisitions in 2017Leading countries in life sciences sector M&As 2017
- Overview
The most important statistics
- Total nominal spending on medicines in the U.S. from 2002 to 2016 (in billion U.S. dollars)*U.S. total medicine spending 2002-2016
- Top 20 U.S. therapy areas based on drug spending in 2016 (in billion U.S. dollars)Leading therapy areas for U.S. drug spending 2016
- Top 20 prescription drugs based on U.S. sales in 2016 (in billion U.S. dollars)*U.S. top 20 prescribed drugs based on sales 2016
- Top 20 U.S. pharma products by dispensed prescriptions in 2016 (in millions)Top U.S. pharma products by prescriptions 2016
- Channel distribution of U.S. pharmaceutical spending from 2014 to 2016 (in billion U.S. dollars)Pharmaceutical channel distribution by U.S. spending 2014-2016
- U.S. pharmaceutical preparation manufacturing gross output from 1998 to 2016 (in million U.S. dollars)*Pharmaceutical preparation manufacturing gross output 1998-2016
- U.S. biopharmaceutical goods export volume from 2002 to 2016 (in billion U.S. dollars)U.S. biopharmaceutical export volume 2002-2016
- Companies
The most important statistics
- 2017 ranking of the top 10 U.S. biotech and pharmaceutical companies based on revenue (in billion U.S. dollars)*2017 list of top U.S. biotech and pharmaceutical companies based on revenue
- Top 20 pharmaceutical corporations by U.S. revenue in 2016 (in billion U.S. dollars)*Pharmaceutical corporations by U.S. revenue 2016
- Johnson & Johnson's total revenue from 2005 to 2017 (in million U.S. dollars)Johnson & Johnson's total revenue 2005-2017
- Pfizer's total revenue from 2006 to 2017 (in million U.S. dollars)Pfizer's total revenue 2006-2017
- Total revenue of Merck & Co. from 2006 to 2017 (in million U.S. dollars)Merck & Co - total revenue 2006-2017
- Advertising expenditure of selected pharmaceutical companies in the United States in 2015 (in thousand U.S. dollars)Ad spending of pharmaceutical companies in the U.S. 2015
- Top pharmaceutical company penalties in the United States between 2012 and 2015 (in million U.S. dollars)*Highest pharmaceutical company penalties in the U.S. 2012-2015
- Top 10 pharmaceutical companies in Canada in 2016, by revenue (in billion Canadian dollars)Top pharmaceutical companies located in Canada by revenue 2016
- Research and development
The most important statistics
- Research and development expenditure of total U.S. pharmaceutical industry from 1995 to 2015 (in billion U.S. dollars)*Research and development expenditure: U.S. pharmaceutical industry 1995-2015
- Spending of U.S. pharmaceutical industry for research and development as a percentage of total revenues from 1990 to 2015U.S. pharma industry R&D spending as a percent of total revenues 1990-2015
- Number of biologic medicines in development as of June 2017, by therapeutic category*Pharmaceuticals: biologic medicines in development 2017 by category
- Cost of developing a drug in the U.S. from the 1970s until today (in million U.S. dollars)*Pharmaceuticals: cost of drug development in the U.S. since 1975
- Number of new molecular entities launched in the U.S. from 2003 to 2015Number of new drugs launched in the U.S. 2003-2015
- Number of FDA approved orphan designations in the United States from 2000 to 2014Number of FDA approved orphan designations in the U.S. 2000-2014
- New medicine brands spending growth in the U.S. from 2011 to 2015 (in billion U.S. dollars)U.S. sales growth of new brand medicines 2011-2015
- Pharmaceutical R&D expenditure per employee compared to other U.S. manufacturing sectors 2000-2013R&D expenditure per employee in U.S. sectors 2000-2013
- Generics
The most important statistics
- Top 20 companies based on unbranded generics U.S. market share during 2014-2015*Market share of unbranded generics by top 20 companies in U.S. 2014-2015
- Change in branded and generic medication spending in the United States from 2009 to 2015 (in billion U.S. dollars)Spending change on branded and generic medicines in the U.S. 2009-2015
- Proportion of branded versus generic prescription drug revenues in the United States from 2005 to 2016U.S. brand and generic prescription drug revenue 2005-2016
- Proportion of branded versus generic drug prescriptions dispensed in the United States from 2005 to 2016Branded vs. generic U.S. drug prescriptions dispensed 2005-2016
- Savings through generic drug usage in the United States from 2008 to 2017 (in billion U.S. dollars)Savings through generic drug usage in the U.S. 2008-2017
- Leading drugs going off patent in the U.S. in 2017, by revenue (in million U.S. dollars)*Biggest selling drugs with patent at threat in the U.S. in 2017, by revenue
- Outlook
The most important statistics
- Projected revenue growth rates of the global pharmaceutical industry in the period 2015-2018, by regionForecast of CAGR global pharmaceutical industry by region 2015-2018
- Forecast of global medicine spending distribution in 2020, by region*Global spending on medicines by regional share forecast 2020
- Projected global pharmaceutical sales for 2021, by region (in billion U.S. dollars)*World pharmaceutical sales by region forecast 2021
- Selected top branded biologic drugs in the United States that will go generic between 2016 and 2028, by revenue (in billion U.S. dollars)*Top branded biologic drugs in the U.S. that will go generic by 2028
- Projected top 25 pharmaceutical products by U.S. revenue in 2024 (in million U.S. dollars)Leading U.S. pharmaceutical products by revenue 2024
- Healthcare and pharmaceutical industry digital advertising spending in the United States from 2011 to 2020 (in billion U.S. dollars)Healthcare and pharmaceutical industry digital ad spend in the U.S. 2011-2020
- The consumer's view
The most important statistics
- How is your overall impression of the U.S. pharma industry?U.S. adults impression of the U.S. pharma industry
- How high do you think the pressure on physicians is from the pharma industry to prescribe certain drugs?U.S. adults that believe physicians are under pressure from pharma to prescribe drugs
- How would you rate the U.S. pharma companies concerning the quality of their drugs?U.S. adults impression of the U.S. pharma drug qualities
- How would you rate the U.S. pharma companies concerning their fairness towards patients?U.S. adults impression of the U.S. pharma companies fairness towards patients
- Percentage of Americans who would rate U.S. pharma companies excellent or good in selected features as of 2017U.S. adults who would rate selected pharma features as excellent or good 2017
- Which of these pharma companies do you prefer when buying drugs?Preferred pharma companies by Americans for drug purchase 2017
- Opinion of Americans on U.S. pharmaceutical product quality compared to foreign products as of 2017*Americans on US pharma quality compared to foreign pharma 2017
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Clinical trials
- 92 page/s
- English
- pptx
- Detailed references
Everything On "Clinical trials" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Other Reports & Dossiers
Statista for Your Company: The Research and Analysis Tool
- Product Film
- Statistics
- Downloads
Our Premium Statistics - facts for your business
Currently, Statista provides more than 1 million statistics.
93 percent (all Premium content) are exclusively accessible via our professional accounts.
Unlimited access
As a Statista Premium customer, you receive unlimited access to all statistics at all times. Including downloads of data in the most common formats (XLS, PDF & PNG). Create relevant and significant statistics in no time.
You are in good company
Google
Samsung
Unilever
Procter and Gamble
Adobe
Telekom
PayPal
Otto
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Americans' impression of the US pharma industry quality of drugs, by ethnicity 2017
- Canada 's global sales share of patented drugs 2005-2016
- Sales growth impact of patented drugs in Canada 2015-2016
- Patented drug 2016 sales share distribution by year of product introduction
- U.S. top 10 prescribed drugs based on market share 2016
- Quantity change of patented drugs in Canada by therapy class 2015-2016
- Patent drug sales impact on change in expenditure by therapy class in Canada 2016
- Patented drug products annual sales change in Canada 1991-2016
- Rate of price change for patented drugs 2016, by country
- Patent applications for genetic drugs worldwide 2010
- Top specialty drug pharmacies in the U.S. by revenue 2017
- Expenditure worldwide on diabetes by market 2013-2018
- Definition of specialty drugs by PBMs and pharmacy executives 2011
- Boehringer Ingelheim's top animal health product revenues 2017
- Genetic drugs: percentage of patents worldwide 2010
- Austria: Bile and other animal glands for pharmaceutical preparation 2012-2017
- Use of blood products in France 2016
- Poland: pharmaceutical goods import value 2012-2017
- United Kingdom (UK): leading pharmaceutical products export partners 2016
- Forecast: revenue optical instrument manufacture Italy 2008-2020
Studies
- Biotechnology Industry in Europe
- Overview of Korean Drug Research Association (KDRA), Korea Health Industry Development Ins...
- Global Participation in Clinical Trials Report 2015-2016
- Unleashing Pharma from the R&D Value Chain
- Pharmaceutical industry in Japan
- The Changing Face of Global Clinical Trials
- The Controversey over Rising Drug Prices: The Public's View
- Life Sciences Outlook United States 2017
- Antibiotic use in the United Kingdom (UK)
- Pharmaceutical industry in Italy
- Putting the Science back into Life Sciences
- The 2018 Genentech Oncology Trend Report
- Life Sciences Outlook United States 2016
- Animal testing in the United Kingdom
- 2015 Global life sciences outlook
Our Business Solutions: Save Time and Money
only
$588*
per yearYour advantages
- Full access to all our statistics
- Download as XLS, PDF & PNG
- Relevant data: complete source information
All functions of our platform illustrated face-to-face
- Learn how Statista supports your company
- Extensive tour across the whole portal
- Personal guidance by our support team
The knowledge database for your company
- All functions of the Premium Account
- Access to dossiers, forecasts and studies
- Access to our international database
- Publishing rights and other exclusive functions
* All products require an annual contract.
Prices do not include sales tax
(New York residents only).
Statistics on the topic
Free statistics
- U.S. pharmaceutical preparation manufacturing gross output from 1998 to 2016 (in million U.S. dollars)*
- Research and development expenditure of total U.S. pharmaceutical industry from 1995 to 2015 (in billion U.S. dollars)*
- Number of new molecular entities launched in the U.S. from 2003 to 2015
- Number of FDA approved orphan designations in the United States from 2000 to 2014
- New medicine brands spending growth in the U.S. from 2011 to 2015 (in billion U.S. dollars)
- Pharmaceutical R&D expenditure per employee compared to other U.S. manufacturing sectors 2000-2013
- Change in branded and generic medication spending in the United States from 2009 to 2015 (in billion U.S. dollars)
- Forecast of global medicine spending distribution in 2020, by region*
- Selected top branded biologic drugs in the United States that will go generic between 2016 and 2028, by revenue (in billion U.S. dollars)*
- How is your overall impression of the U.S. pharma industry?
- Percentage of Americans who would rate U.S. pharma companies excellent or good in selected features as of 2017
- Which of these pharma companies do you prefer when buying drugs?
- Opinions on the quality of drugs made by U.S. pharma companies as of 2017, by ethnicity
- Canada's share of global drug sales from 2005 to 2016
- Patented drugs sales impact in Canada between 2015 and 2016 (in million Canadian dollars)
- Distribution of Canada's patented drug sales generated in 2016, by year of product introduction
- Top 10 prescription drugs based on U.S. market share in 2016 (in billion U.S. dollars)*
- Patented drugs quantity changes in Canada between 2015 and 2016, by therapeutic class*
- Patented drug sales impact on changes in expenditure in Canada by therapeutic class in 2016
- Patented drugs average price change in 2016, by country
- Diabetes spending in developed and pharmerging markets from 2013 to 2018 (in billion U.S. dollars)*
- Share of indications which define a specialty drug as of 2011*
- Revenues of Boehringer Ingelheim's top animal health products in 2017 (in million euros)
- Value of pharmaceutical goods imported to Poland from 2012 to 2017 (in 1,000 euro)
Premium Statistics
- Distribution of the total global pharmaceutical market sales from 2014 to 2017, by submarket*
- Global pharmaceutical sales from 2015 to 2017, by region (in billion U.S. dollars)*
- Market share of top 10 national pharmaceutical markets worldwide in 2016*
- Growth of top 10 national pharmaceutical markets worldwide from 2011 to 2016*
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2017 (in billion U.S. dollars)
- Leading countries in global life sciences mergers and acquisitions in 2017
- Total nominal spending on medicines in the U.S. from 2002 to 2016 (in billion U.S. dollars)*
- Top 20 U.S. therapy areas based on drug spending in 2016 (in billion U.S. dollars)
- Top 20 prescription drugs based on U.S. sales in 2016 (in billion U.S. dollars)*
- Top 20 U.S. pharma products by dispensed prescriptions in 2016 (in millions)
- Channel distribution of U.S. pharmaceutical spending from 2014 to 2016 (in billion U.S. dollars)
- U.S. biopharmaceutical goods export volume from 2002 to 2016 (in billion U.S. dollars)
- 2017 ranking of the top 10 U.S. biotech and pharmaceutical companies based on revenue (in billion U.S. dollars)*
- Top 20 pharmaceutical corporations by U.S. revenue in 2016 (in billion U.S. dollars)*
- Johnson & Johnson's total revenue from 2005 to 2017 (in million U.S. dollars)
- Pfizer's total revenue from 2006 to 2017 (in million U.S. dollars)
- Total revenue of Merck & Co. from 2006 to 2017 (in million U.S. dollars)
- Advertising expenditure of selected pharmaceutical companies in the United States in 2015 (in thousand U.S. dollars)
- Top pharmaceutical company penalties in the United States between 2012 and 2015 (in million U.S. dollars)*
- Top 10 pharmaceutical companies in Canada in 2016, by revenue (in billion Canadian dollars)
- Spending of U.S. pharmaceutical industry for research and development as a percentage of total revenues from 1990 to 2015
- Number of biologic medicines in development as of June 2017, by therapeutic category*
- Cost of developing a drug in the U.S. from the 1970s until today (in million U.S. dollars)*
- Top 20 companies based on unbranded generics U.S. market share during 2014-2015*
- Proportion of branded versus generic prescription drug revenues in the United States from 2005 to 2016
- Proportion of branded versus generic drug prescriptions dispensed in the United States from 2005 to 2016
- Savings through generic drug usage in the United States from 2008 to 2017 (in billion U.S. dollars)
- Leading drugs going off patent in the U.S. in 2017, by revenue (in million U.S. dollars)*
- Projected revenue growth rates of the global pharmaceutical industry in the period 2015-2018, by region
- Projected global pharmaceutical sales for 2021, by region (in billion U.S. dollars)*
- Projected top 25 pharmaceutical products by U.S. revenue in 2024 (in million U.S. dollars)
- Healthcare and pharmaceutical industry digital advertising spending in the United States from 2011 to 2020 (in billion U.S. dollars)
- How high do you think the pressure on physicians is from the pharma industry to prescribe certain drugs?
- How would you rate the U.S. pharma companies concerning the quality of their drugs?
- How would you rate the U.S. pharma companies concerning their fairness towards patients?
- Opinion of Americans on U.S. pharmaceutical product quality compared to foreign products as of 2017*
- Patented drug products annual sales change in Canada from 1991 to 2016
- Number of patent applications for genetically engineered drugs worldwide in 1990 and 2010
- Top 10 pharmacies based on specialty drug revenue in the U.S. in 2017 (in billion U.S. dollars)
- Distribution of patents for genetically engineered drugs by country in 1990, 2008 and 2010 (in percent)
- Value of bile and other animal glands for pharmaceutical preparation exported from Austria from 2012 to 2017 (in 1,000 euros)
- Breakdown of the use of blood products in France in 2016
- Leading destinations of pharmaceutical products exported from the United Kingdom (UK) in 2016, based on value (in 1,000 U.S. dollars)
- Revenue of optical instrument manufacture (NACE Rev. 2 C2670) in Italy from 2008 to 2020 (in million U.S. dollars)
Statista Accounts: Access All Statistics. Starting from $588 / Year
Topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Exclusive Premium functionality
Register in seconds and access exclusive features.
- Full access:
To this and over 1 million additional datasets - Save Time:
Downloads allow integration with your project - Valid data:
Access to all sources and background information
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
2 News
Latest News
New
New Market: Luxury Goods
The Consumer Market Outlook now includes historical market sizes and forecasts for 9 personal luxury goods categories as well as company data on key players in 50 countries.
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.